Inhibikase Therapeutics I...
(IKT)
undefined
undefined%
At close: undefined
3.32
-0.60%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 260.50K | 123.44K | 3.10M | 698.47K | 1.12M | 4.04M | 2.06M | 967.39K |
| Cost of Revenue | 13.62M | 6.72K | 11.36M | 893.80K | 2.55M | 3.65M | 1.76M | 846.39K |
| Gross Profit | -13.36M | 116.72K | -8.26M | -195.33K | -1.43M | 393.85K | 305.25K | 121.00K |
| Operating Income | -20.09M | -18.13M | -14.77M | -2.82M | -5.70M | -2.12M | -405.13K | -613.29K |
| Interest Income | 1.06M | 74.45K | 19.92K | 29.40K | 24.84K | n/a | 30.95K | 15.45K |
| Pretax Income | -19.03M | -18.05M | -14.79M | -2.85M | -5.72M | -2.15M | -436.07K | -628.74K |
| Net Income | -19.03M | -17.91M | -14.81M | -2.88M | -5.75M | -2.15M | -436.07K | -628.74K |
| Selling & General & Admin | 6.73M | 6.22M | 6.51M | 2.62M | 4.27M | 2.52M | 710.38K | 734.29K |
| Research & Development | 13.62M | 12.03M | 11.36M | 893.80K | 2.55M | 3.65M | 1.76M | 846.39K |
| Other Expenses | -13.62M | -123.44K | -3.10M | -698.47K | -1.12M | n/a | n/a | n/a |
| Operating Expenses | 6.73M | 18.13M | 14.77M | 2.82M | 5.70M | 2.12M | 2.47M | 734.29K |
| Interest Expense | n/a | 74.45K | 19.92K | 29.40K | 24.84K | 30.33K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 20.35M | 18.13M | 14.77M | 2.82M | 5.70M | 2.12M | 2.47M | 1.58M |
| Income Tax | n/a | -148.91K | 19.92K | 29.40K | 24.84K | -161.14K | -405.13K | -15.45K |
| Shares Outstanding (Basic) | 5.33M | 4.20M | 3.03M | 1.68M | 1.72M | 1.34M | 1.72M | 1.30M |
| Shares Outstanding (Diluted) | 5.33M | 4.20M | 3.03M | 1.68M | 1.72M | 1.34M | 1.72M | 1.30M |
| EPS (Basic) | -3.57 | -4.26 | -4.88 | -1.72 | -3.34 | -1.61 | -0.25 | -0.48 |
| EPS (Diluted) | -3.57 | -4.26 | -4.88 | -1.72 | -3.34 | -1.61 | -0.25 | -0.48 |
| EBITDA | -19.91M | -18.12M | -14.77M | -2.82M | -5.70M | n/a | n/a | n/a |
| Depreciation & Amortization | 177.40K | 6.72K | 14.77M | 2.82M | 5.70M | 2.12M | 405.13K | 613.29K |